Please login to the form below

Not currently logged in
Email:
Password:

Research Partnership expands across America

Firm opens new offices in San Francisco and New York

Research PartnershipHealthcare market research and consulting agency Research Partnership has expanded its US capabilities with new offices opening in San Francisco and New York.

Director Tom Winter has relocated from London to San Francisco to better service West Coast clients while director Rachel Howard focuses on the New York office to continue to build emerging market business and to provide a US hub for syndicated business.

Mary Assimakopoulos, founding director of Research Partnership, said: “Research Partnership is celebrating its 20th anniversary this year.

“We have become one of the targets independent global healthcare market research agencies and our further expansion in the US is in line with our key objective for achieving continued growth in this key market.”

Both directors will manage a team of researchers and the new offices will support the regional office in Boston and the company’s US headquarters in Philadelphia.

Article by
Gemma Jones

22nd May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics